Search Results - "Maples, P"

Refine Results
  1. 1

    Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer by NEMUNAITIS, John, STERNUM, Daniel, HEGE, Kristen, JABLONS, David, SMITH, John W, FOX, Bernard, MAPLES, Phil, HAMILTON, Scott, BORELLINI, Flavia, LIN, Andy, MORALI, Sayeh

    “…To evaluate the feasibility, safety, and efficacy of vaccination with autologous tumor cells genetically modified with an adenoviral vector (Ad-GM) to secrete…”
    Get full text
    Journal Article
  2. 2

    Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients by Nemunaitis, J, Nemunaitis, M, Senzer, N, Snitz, P, Bedell, C, Kumar, P, Pappen, B, Maples, P B, Shawler, D, Fakhrai, H

    Published in Cancer gene therapy (01-08-2009)
    “…In a previous dose escalation trial we demonstrated dose related survival correlation to Belagenpumatucel-L. In order to further evaluate safety and response…”
    Get full text
    Journal Article
  3. 3

    A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients by Nemunaitis, J, Senzer, N, Sarmiento, S, Zhang, Y-A, Arzaga, R, Sands, B, Maples, P, Tong, A W

    Published in Cancer gene therapy (01-11-2007)
    “…ONYX-015 is an attenuated chimeric human group C adenovirus, which preferentially replicates in and lyses tumor cells that are p53 negative. The purpose of…”
    Get full text
    Journal Article
  4. 4

    Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity by NEMUNAITIS, J, CUNNINGHAM, C, KIRN, D, BUCHANAN, A, BLACKBURN, A, EDELMAN, G, MAPLES, P, NETTO, G, TONG, A, RANDLEV, B, OLSON, S

    Published in Gene therapy (01-05-2001)
    “…Although genetically engineered adenoviruses hold promise for the treatment of cancer, clinical trial reports have utilized intratumoral injection to date. To…”
    Get full text
    Journal Article
  5. 5

    Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform by Wu, J, Liu, S, Yu, J, Zhou, G, Rao, D, Jay, C M, Kumar, P, Sanchez, R, Templeton, N, Senzer, N, Maples, P, Nemunaitis, J, Brunicardi, F C

    Published in Cancer gene therapy (01-02-2014)
    “…RNA interference (RNAi) represents a powerful, new tool for scientific investigation as well as a promising new form of targeted gene therapy, with…”
    Get full text
    Journal Article
  6. 6

    Immune response and survival of refractory cancer patients who received TGF- beta 2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine by Nemunaitis, J, Senzer, N, Olivares, J, Kumar, P, Barve, M, Kuhn, J, Nemunaitis, T, Magee, M, Yu, Y, Wallraven, G, Pappen, B O, Maples, P B

    Published in Gene therapy (01-09-2013)
    “…TAG vaccine is a novel 'triad vaccine' that involves transfection of autologous tumor with a dual plasmid, TGF beta 2 antisense gene and GM-CSF gene. Patients…”
    Get full text
    Journal Article
  7. 7

    Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine by Nemunaitis, J, Senzer, N, Olivares, J, Kumar, P, Barve, M, Kuhn, J, Nemunaitis, T, Magee, M, Yu, Y, Wallraven, G, Pappen, B O, Maples, P B

    Published in Gene therapy (01-09-2013)
    “…TAG vaccine is a novel ‘triad vaccine’ that involves transfection of autologous tumor with a dual plasmid, TGFβ2 antisense gene and GM-CSF gene. Patients with…”
    Get full text
    Journal Article
  8. 8

    Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference by Rao, D D, Maples, P B, Senzer, N, Kumar, P, Wang, Z, Pappen, B O, Yu, Y, Haddock, C, Jay, C, Phadke, A P, Chen, S, Kuhn, J, Dylewski, D, Scott, S, Monsma, D, Webb, C, Tong, A, Shanahan, D, Nemunaitis, J

    Published in Cancer gene therapy (01-11-2010)
    “…RNA interference (RNAi) is a natural cellular regulatory process that inhibits gene expression by transcriptional, post-transcriptional and translational…”
    Get full text
    Journal Article
  9. 9

    Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine by Jay, C M, Ruoff, C, Kumar, P, Maass, H, Spanhel, B, Miller, M, Arrington, A, Montalvo, N, Gresham, V, Rao, D D, Evans, C, Wang, Z, Brunicardi, F C, Liu, S-H, Zhou, G, Senzer, N, Nemunaitis, J, King, L, Weeks, B, Clubb, F J, Fossum, T W, Maples, P B

    Published in Cancer gene therapy (01-12-2013)
    “…PDX1 (pancreatic and duodenal homeobox 1) is overexpressed in pancreatic cancer, and its reduction results in tumor regression. Bi-functional pbi-shRNA PDX1…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cellular immune profile of patients with advanced cancer before and after taxane treatment by TONG, A. W, SEAMOUR, B, LAWSON, J. M, ORDONEZ, G, VUKELJA, S, HYMAN, W, RICHARDS, D, STEIN, L, MAPLES, P. B, NEMUNAITIS, J

    Published in American journal of clinical oncology (01-10-2000)
    “…The purpose of this study is to determine immune recovery and function after treatment with docetaxel or paclitaxel. Peripheral blood mononuclear cells were…”
    Get full text
    Journal Article
  12. 12

    Proof concept for clinical justification of network mapping for personalized cancer therapeutics by Nemunaitis, J, Senzer, N, Khalil, I, Shen, Y, Kumar, P, Tong, A, Kuhn, J, Lamont, J, Nemunaitis, M, Rao, D, Zhang, Y-A, Zhou, Y, Vorhies, J, Maples, P, Hill, C, Shanahan, D

    Published in Cancer gene therapy (01-08-2007)
    “…To identify signature targets associated with patient-specific cancer lesions based on tumor versus normal tissue differential protein and mRNA coexpression…”
    Get full text
    Journal Article
  13. 13

    The Bloxsom Air Lock: A Historical Perspective by Kendig, James W, Maples, Philip G, Maisels, M. Jeffrey

    Published in Pediatrics (Evanston) (01-12-2001)
    “…In 1950, Allan P. Bloxsom (1901-1991), a pediatrician at the St Joseph Hospital in Houston, introduced his positive pressure oxygen air lock (AL) for the…”
    Get full text
    Journal Article
  14. 14

    Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow by Smith, S L, Bender, J G, Maples, P B, Unverzagt, K, Schilling, M, Lum, L, Williams, S, Van Epps, D E

    Published in Experimental hematology (01-07-1993)
    “…The growth and differentiation of selected bone marrow CD34+ cells stimulated with hematopoietic growth factors in lipid cultures were evaluated to determine…”
    Get more information
    Journal Article
  15. 15

    Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer by Tong, Alex W., Zhang, Yu-An, Cunningham, Casey, Maples, Phillip, Nemunaitis, John

    Published in Clinical lung cancer (01-02-2001)
    “…Non–small-cell lung cancer frequently contains oncogenetic defects (mutations in ras, retinoblastoma, and p53 genes) that contribute to disease…”
    Get full text
    Journal Article
  16. 16

    Development and validation of a low-literacy Chronic Obstructive Pulmonary Disease knowledge Questionnaire (COPD-Q) by Maples, Paula, Franks, Andrea, Ray, Shaunta, Stevens, Amy Barger, Wallace, Lorraine S

    Published in Patient education and counseling (01-10-2010)
    “…Abstract Objective The objective of this study was to develop a content valid, understandable, readable, and reliable Chronic Obstructive Pulmonary Disease…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Immune response and survival of refractory cancer patients who received TGF-[beta]2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine by Nemunaitis, J, Senzer, N, Olivares, J, Kumar, P, Barve, M, Kuhn, J, Nemunaitis, T, Magee, M, Yu, Y, Wallraven, G, Pappen, B O, Maples, P B

    Published in Gene therapy (01-09-2013)
    “…TAG vaccine is a novel 'triad vaccine' that involves transfection of autologous tumor with a dual plasmid, TGF[beta]2 antisense gene and GM-CSF gene. Patients…”
    Get full text
    Journal Article
  20. 20

    Differential expression of alpha- and beta-globin genes in erythroleukemic cell lines by BERU, N, MAPLES, P. B, HERMINE, O, GOLDWASSER, E

    Published in Molecular and Cellular Biology (01-07-1990)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article